Medical Oncologist
CION Cancer Clinics
Antiviral treatment lowers liver cancer risk, but does not remove it | CION Cancer Clinics
Yes, tenofovir and entecavir lower the chance of liver cancer in people with hepatitis B who need treatment. They do not remove it, so regular scans continue if you were advised to have them. This page explains why the tablets help, why some risk stays even with an undetectable viral load, and how to get the most protection from treatment. At CION Cancer Clinics, our specialists help you understand your own risk and plan regular liver checks that fit it.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Do tenofovir and entecavir reduce liver cancer risk?
- If the virus is suppressed, why can cancer still happen?
- What antiviral treatment changes, and what it does not
- How do I get the most protection from treatment?
- What people on antivirals often believe, and what is true
- Who this does not apply to, and what this page cannot tell you
- Common questions about antivirals and liver cancer risk
The short answer
Do tenofovir and entecavir reduce liver cancer risk?
Yes. For people with hepatitis B who need treatment, long-term tenofovir or entecavir lowers the chance of developing liver cancer. It does not bring that chance down to zero, so anyone who was advised to have regular liver scans should keep having them while on tablets.
This page is about primary liver cancer, hepatocellular carcinoma or HCC, the kind that starts in liver cells and is linked to hepatitis B. If you were told a cancer elsewhere has spread to your liver, read why cancer in the liver is not always liver cancer instead.
Why the tablets help
Both medicines stop the hepatitis B virus from copying itself. The viral load falls, often until the blood test can no longer detect it. With less virus, the liver is less inflamed, scarring slows and in some people partly improves, and the cells divide less often. Each of these takes pressure off the liver.
Lower risk is a real gain. It is still a risk, and scans are how it is watched.Why some risk stays
If the virus is suppressed, why can cancer still happen?
Antivirals control the virus. They cannot undo everything it did before treatment started.
The virus is already inside liver DNA
Hepatitis B can write pieces of its genetic material into the DNA of liver cells. Tablets stop new copying, but those inserted pieces stay. Some of that damage was done years before anyone knew about the infection.
A reservoir the tablets do not clear
The virus keeps a stable store of its genes inside the nucleus of infected cells. Current medicines silence it without removing it, which is why hepatitis B is controlled rather than removed.
Scarring that came first
If cirrhosis or advanced fibrosis was present when treatment started, that scarred tissue still carries a raised risk of cancer, even when the virus is fully controlled.
Risk stays higher with
- Cirrhosis at the start of treatment
- Older age and male sex
- A family history of liver cancer
- Diabetes, fatty liver or alcohol on top
Tablets only work if they are taken
Missed doses let the virus climb back. Stopping suddenly can trigger a dangerous flare. Read why stopping hepatitis B medicine is risky before changing anything.
Not sure whether this applies to you?
Ask an oncologistSide by side
What antiviral treatment changes, and what it does not
What the tablets do
What they cannot do
Bring the viral load down, often to undetectable
Remove the virus's genes already in liver cells
Calm inflammation and protect liver function
Reverse cirrhosis completely in most people
Lower the chance of liver cancer over time
Make liver cancer impossible
Lower the risk of passing the virus on
Replace vaccination for the family
While you are on tablets
How do I get the most protection from treatment?
Take the tablet every day, without gaps
Set a daily phone reminder. Refill before you run out, especially before travelling to your village or to family for a long stay.
Keep your blood tests
Viral load and liver tests show whether treatment is working. Why the viral load number matters explains what the result means.
Keep your surveillance scans
If you were advised to have an ultrasound every six months, with or without an AFP blood test, that plan continues on treatment. CION arranges scans through diagnostic partners and the team reviews the results.
Reduce what adds to the risk
Cutting down or stopping alcohol, managing diabetes and weight, and avoiding unprescribed herbal liver tonics all help the same liver the tablets are protecting.
Tell every doctor you are on antivirals
This matters most before chemotherapy, immunotherapy or steroids, which can affect hepatitis B. See hepatitis B and cancer treatment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What people on antivirals often believe, and what is true
"My viral load is undetectable, so I can stop the scans."
An undetectable viral load is the goal of treatment and a very good result. It lowers cancer risk without removing it, so the scan plan your doctor set usually stays the same.
"I have been on tablets for years, so I can stop now."
For most people, hepatitis B treatment is long-term. Stopping without a specialist's plan can cause a sudden flare that damages the liver. Only your hepatologist or physician should decide this.
"The tablets themselves cause liver cancer."
They do not. They lower the risk. When cancer is found in someone on treatment, it usually reflects damage done before treatment began, or risk factors the tablets cannot touch.
"A liver tonic will clean out what the tablets miss."
No herbal product removes hepatitis B, and some can injure the liver, especially one already scarred. If you take anything, tell your doctor. Nobody will judge you for it.
Being straight with you
Who this does not apply to, and what this page cannot tell you
Not everyone with hepatitis B needs tablets. Many inactive carriers with a low viral load and normal liver tests are watched with blood tests instead. For them, this page explains a decision their doctor has not yet made. Antivirals do not suit people whose hepatitis B is inactive and whose liver shows no damage, and starting them without a plan brings the risk of stopping later.
It cannot tell you your own risk
The size of the benefit depends on your liver before treatment, your age, your family and everything else your liver is dealing with. Only a specialist who has seen all your results can say where you stand. Evidence comparing tenofovir and entecavir head to head is mixed, and the choice between them is made on your kidneys, bones and history.
Who to ask
Antiviral decisions belong to a hepatologist or physician. Both medicines are available in India as tablets, and the national viral hepatitis programme offers testing and treatment at designated government centres; check the current details there. If cancer has already been found, a CION oncologist plans that care alongside your liver specialist.
Questions we are asked
Common questions about antivirals and liver cancer risk
Does entecavir or tenofovir prevent liver cancer?
They lower the risk in people with hepatitis B who need treatment, and the benefit builds the longer the virus stays suppressed. They do not prevent cancer completely. That is why people in a surveillance group keep having scans while on treatment.
Is tenofovir better than entecavir for cancer risk?
Studies comparing them give mixed answers, and neither has been clearly shown to be better at lowering cancer risk. Your doctor chooses based on your kidneys, bone health, earlier treatment and other medicines. Both work well when taken every day.
Why do I still need scans if my virus is undetectable?
Because the virus's genes already inside liver cells, and any scarring from before treatment, still carry some risk. Scans find a tumour while it is small, when treatment options are widest. Read why scans continue on treatment.
Can I stop antivirals once my liver tests are normal?
Do not stop on your own. Normal results usually mean the tablets are working. Stopping can cause the virus to return quickly and inflame the liver, sometimes severely. A specialist may consider stopping in a few specific situations, with close blood test follow-up.
Does hepatitis B ever go away completely?
Rarely. Some people lose the surface antigen, HBsAg, which is the closest thing to clearing the virus, and their cancer risk falls further. Even then, a small risk remains, so your doctor will still advise on follow-up.
I missed tablets for a few weeks. What should I do?
Restart and tell your doctor soon. They may check your viral load and liver tests to make sure the virus has not flared. If you have yellow eyes, dark urine, vomiting or severe tiredness, go to a doctor today.
Do antivirals help if I already have liver cancer?
Yes, they are usually continued or started. Keeping the virus suppressed protects the liver, which matters for every cancer treatment that depends on liver function. Your oncologist and liver specialist plan this together.
Can CION help me with this?
CION oncologists can review your reports, explain your cancer risk and plan surveillance scans. Antiviral treatment is guided by a hepatologist, and CION coordinates that through partner specialists. Call the helpline if you are unsure where to begin.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NIDDK — Hepatitis B - NIDDK
- Liver UK (formerly British Liver Trust) — Hepatitis B in adults
- National Cancer Institute — Liver Cancer Causes, Risk Factors, and Prevention
- National Viral Hepatitis Control Program (MoHFW) — National Viral Hepatitis Control Program
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Why you still need scans on antiviral treatmentThe surveillance plan, explained for people on tabletsStopping hepatitis B medicine: why it is riskyRead this before changing your tabletsHepatitis B viral load and why the number mattersWhat your blood result is telling youCan hepatitis B cause liver cancer without cirrhosis?Why a normal-looking liver still needs watching
Talk to us
On antivirals and unsure whether you still need scans?
Bring your viral load reports and scans, and a CION oncologist will explain your cancer risk and what follow-up makes sense. One helpline serves every CION centre.